Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biosynex SA (ALBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8201
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers tests such as TDR and TROD, immunoquick contact amnioquick, immunoquick, and immunoquick elifa, among others. Biosynex’s products are used in the therapeutic areas such as infectious diseases, emergency markers, obstetric, parasitology and virology, tropical diseases, and autoimmune diseases, among others. The company provides its products to the professionals in nurseries, midwives, and clinical labs, among others. It markets its products through its distributors. Biosynex is headquartered in Strasbourg, France.

Biosynex SA (ALBIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosynex SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosynex SA, Medical Devices Deals, 2012 to YTD 2018 9
Biosynex SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosynex SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ellen Enters into Distribution Agreement with Biosynex 11
Merger 12
Biosynex to Merge with Prodiag 12
Equity Offering 13
Biosynex Raises USD2.5 Million in Private Placement of Shares 13
Biosynex Raises USD2.2 Million in Rights Offering of Shares 14
Biosynex Raises USD1.2 Million in Rights Offering of Shares 15
Biosynex SA – Key Competitors 16
Biosynex SA – Key Employees 17
Biosynex SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Biosynex SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosynex SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosynex SA, Deals By Therapy Area, 2012 to YTD 2018 8
Biosynex SA, Medical Devices Deals, 2012 to YTD 2018 9
Biosynex SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ellen Enters into Distribution Agreement with Biosynex 11
Biosynex to Merge with Prodiag 12
Biosynex Raises USD2.5 Million in Private Placement of Shares 13
Biosynex Raises USD2.2 Million in Rights Offering of Shares 14
Biosynex Raises USD1.2 Million in Rights Offering of Shares 15
Biosynex SA, Key Competitors 16
Biosynex SA, Key Employees 17
Biosynex SA, Subsidiaries 18

List of Figures
Biosynex SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosynex SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosynex SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosynex SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Jamba, Inc.:企業の戦略・SWOT・財務分析
    Jamba, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jamba, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Esterline Technologies Corporation:企業の戦略・SWOT・財務情報
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CymaBay Therapeutics Inc (CBAY):製薬・医療:M&Aディール及び事業提携情報
    Summary CymaBay Therapeutics Inc (CymaBay), formerly Metabolex Inc is a clinical-stage biopharmaceutical company that develops therapeutics to treat diabetes, orphan diseases and related metabolic disorders. The company’s pipeline products comprise Arhalofenate, an oral small molecule intended for t …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) is a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cement, fert …
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • GREENoneTEc Solarindustrie GmbH:企業の戦略的SWOT分析
    GREENoneTEc Solarindustrie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Colbun SA:発電所・企業SWOT分析
    Colbun SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Metcash Limited:企業の戦略・SWOT・財務情報
    Metcash Limited - Strategy, SWOT and Corporate Finance Report Summary Metcash Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務分析
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務情報
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kenon Holdings Ltd (KEN):企業の財務・戦略的SWOT分析
    Kenon Holdings Ltd (KEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TRACON Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    TRACON Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TRACON Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Vergnet SA (ALVER)-エネルギー分野:企業M&A・提携分析
    Summary Vergnet SA (Vergnet) is a renewable energy company. It designs, develops, and manufactures renewable solutions. The company offers wind, solar and hybrid energy solutions besides solar applications. Through its technology Hybrid Wizard, Vergnet offers real-time hybrid controller solutions fo …
  • Seagate Technology Public Limited Company:企業のM&A・事業提携・投資動向
    Seagate Technology Public Limited Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seagate Technology Public Limited Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Ebara Corp (6361):企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆